Status: current, Primitive. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4837091000168116 | Hyoscine Butylbromide (AFT) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4837101000168114 | Hyoscine Butylbromide (AFT) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hyoscine Butylbromide (AFT) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 1 mL ampoule | Is a | True | Hyoscine Butylbromide (AFT) | Inferred relationship | Some | |
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (AFT) | Inferred relationship | Some | |
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 5 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (AFT) | Inferred relationship | Some |
Reference Sets
FHIR